Toyonaka, Japan

Jun Hidaka

This inventor holds 2 USPTO granted patents. Top assignees: Dainippon Sumitomo Pharma Co., Ltd., Sumitomo Pharmaceuticals Company Limited. Active years: 2004-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Hidaka. Retrieved from https://idiyas.com/inventor/jun-hidaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2004-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jun Hidaka: Innovator in Recombinant Human Proteins

Introduction

Jun Hidaka is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant human proteins. His work has led to advancements that may have important implications for medical research and therapeutic applications.

Latest Patents

Jun Hidaka holds 2 patents related to recombinant human SM-11044-binding receptor proteins. His latest patents include innovative methods for transforming cells to express a recombinant human SMBP at elevated levels. These methods allow for the measurement of ligand-binding activity, which is crucial for understanding the functionality of these proteins. Additionally, his patents describe a screening system for human SMBP agonists and antagonists, which can be utilized to identify potential therapeutic agents.

Career Highlights

Throughout his career, Jun Hidaka has worked with prominent companies in the pharmaceutical industry. He has been associated with Dainippon Sumitomo Pharma Co., Ltd. and Sumitomo Pharmaceuticals Company Limited. His experience in these organizations has contributed to his expertise in the field of recombinant proteins and their applications.

Collaborations

Jun Hidaka has collaborated with several professionals in his field, including Toshinari Sugasawa and Hajime Kawakami. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in biotechnology.

Conclusion

Jun Hidaka's contributions to the field of recombinant human proteins demonstrate his commitment to advancing medical science. His patents and collaborations reflect a dedication to innovation that may pave the way for future breakthroughs in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…